Have a personal or library account? Click to login
Decreased ABH blood group antigen expression associated with preleukemic conditions and acute leukemia: loss of detectable B, then A antigens in a group AB patient progressing from a myelodysplastic syndrome to leukemia Cover

Decreased ABH blood group antigen expression associated with preleukemic conditions and acute leukemia: loss of detectable B, then A antigens in a group AB patient progressing from a myelodysplastic syndrome to leukemia

By: K. Benson  
Paid access
|Dec 2020

References

  1. 1. van Loghem JJ, Dorfmeier H, van der Hart M. Two A antigens with abnormal serologic properties. Vox Sang 1957;2:1624.10.1159/000478290
  2. 2. Stratton F, Renton PH, Hancock JA. Red cell agglutinability affected by disease. Nature 1958;181:62–3.10.1038/181062a0
  3. 3. Gold ER, Tovey GH, Benney WE, Lewis FJW. Changes in the group A antigen in a case of leukaemia. Nature 1959;183:892–3.10.1038/183892a0
  4. 4. Hoogstraten B, Rosenfield RE, Wasserman LR. Change of ABO blood type in a patient with leukemia. Transfusion 1961;1:32–5.10.1111/j.1537-2995.1961.tb00008.x
  5. 5. Renton PH. Stratton F. Gunson HH, Hancock JA. Red cells of all four ABO groups in a case of leukaemia. Br Med J 1962;i:294–7.10.1136/bmj.1.5274.294
  6. 6. McGinniss MH, Kirkham WR, Schmidt PJ. Modified expression of the ABO, I, and H antigens in acute myelogenous leukemia (abstract). Transfusion 1964;4:310.
  7. 7. Tovey GH, Lockyer JW, Tierney RBH. Changes in Rh grouping reactions in a case of leukaemia. Vox Sang 1961;6:628–31.10.1111/j.1423-0410.1961.tb03215.x
  8. 8. Kolins J. Holland PV. McGinniss MH. Multiple red cell antigen loss in acute granulocytic leukemia. Cancer 1978;42:2248–53.10.1002/1097-0142(197811)42:5<;2248::AID-CNCR2820420524>3.0.CO;2-T
  9. 9. Kassulke JT, Hallgren HM, Yunis EJ. Studies of red cell isoantigens on peripheral leukocytes from normal and leukemic individuals. Am J Pathol 1969;56:333–9.
  10. 10. Kolins J, Allgood JW,Bu rghardt DC, Klein HG, McGinniss MH. Modifications of B, I, i, and Lewis b antigens in a patient with DiGuglielmo's erythroleukemia. Transfusion 198020574–7.
  11. 11. Anstall HB. ABH antigens in disease. In: Wallace ME, Gibbs FL, eds. Blood group systems: ABH and Lewis. Arlington, VA: American Association of Blood Banks; 1986:135–55.
  12. 12. Gralnick HR, Galton DAG, Catovsky D, Sultan C, Bennett JM. Classification of acute leukemia. Ann Int Med 1977;87:740–53.10.7326/0003-4819-87-6-740
  13. 13. Walker RH, ed. Technical manual. 10th ed. Arlington, VA: American Association of Blood Banks, 1990:539–44.
  14. 14. Richards AG. Loss of blood group B antigen in chronic lymphatic leukaemia. Lancet 1962;11:178.10.1016/S0140-6736(62)90057-0
  15. 15. Kahn A, Vroclans M, Hakim J, Boivin P. Differences in the two red cell populations in erythroleukaemia (letter). Lancet 1971;2:933.10.1016/S0140-6736(71)92555-4
  16. 16. Ayres M, Salzano FM, Ludwig OK. Blood group changes in leukaemia. J Med Genet 1966;3:180–5.10.1136/jmg.3.3.180
  17. 17. Saichua S, Chiewsilp P. Red cell ABH antigens in leukaemias and lymphomas. Vox Sang 1978;35:154–9.10.1111/j.1423-0410.1978.tb02915.x
  18. 18. Walker RH, ed. Technical manual. 10th ed. Arlington, VA: American Association of Blood Banks; 1990:174.
  19. 19. Clausen H, Hakomori S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution, Vox Sang 1989;56:1–20.
  20. 20. Kay HEM. A and B antigens of normal and malignant cells. Br J Cancer 1957;7:409–14.10.1038/bjc.1957.49
  21. 21. Kay HEM, Wallace DM. A and B antigens of tumors arising from urinary epithelium. J Natl Cancer Inst 1961;26: 1349–65.
  22. 22. Davidsohn I. Early immunologic diagnosis and prognosis of carcinoma. Am J Clin Pathol 1972;57:715–30.10.1093/ajcp/57.6.715
  23. 23. Bishop MC. Blood group antigens and bladder cancer. Br Med j 1982;284:142–7.10.1136/bmj.284.6327.1426-a
  24. 24. Borgstrom E. Wahren B. Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma. Cancer 1986;58:2428–34.10.1002/1097-0142(19861201)58:11<;2428::AID-CNCR2820581113>3.0.CO;2-I
  25. 25. Orntoft TF, Wolf H, Clausen H, Dabelsteen E, Hakomori S-I. Blood group ABH-related antigens in normal and malignant bladder umthelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas. Int J Cancer 1989;43:774–80.10.1002/ijc.2910430505
  26. 26. Kovark S, Davidsohn I, Stejskal R. ABO antigens in cancer. Detection with the mixed cell agglutination reaction. Arch Pathol 1968;86:12–21.
  27. 27. Rohey-Cafferty SS, El-Naggar AK, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. Am J Clin Pathol 1991;95:844–9.10.1093/ajcp/95.6.844
  28. 28. To ACW, Soong S-J, Shingleton HM, et al. Immunohistochemistry of the blood group A, B, H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervix. Cancer 1986; 58:2435–9.10.1002/1097-0142(19861201)58:11<;2435::AID-CNCR2820581114>3.0.CO;2-N
  29. 29. Schoentag R, Williams V, Kuhns S. The distribution of blood group substance H and CEA in colorectal carcinoma. Cancer 1984;53:503–9.10.1002/1097-0142(19840201)53:3<;503::AID-CNCR2820530323>3.0.CO;2-J
  30. 30. Dandsohn I, Kovarik S, Lee CL. A, B, and O substances in gastrointestinal carcinoma. Arch Pathol 1966;81:381–90.
  31. 31. Lee JS, Ro JY, Sahin AA, et al. Expression of blood group antigen A-a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084–90.10.1056/NEJM1991041832416031848917
  32. 32. Oriol R, Danilovs J, Hawkins BR. A new genetic model proposing that the Se gene is a structured gene closely linked to the H gene. Am J Hum Gen 1981;33:421–31.
  33. 33. Crookston MC. Anomalous ABO, H, and Ii phenotypes in disease. In: Garratty G, ed. Blood group antigens and disease. Arlington, VA: American Association of Blood Banks; 198367–84.
  34. 34. Becker AJ, McCulloch EA, Till J.E. Cytological demonstrations of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197:452–4.10.1038/197452a013970094
  35. 35. Lloyd KO. Blood group antigens as markers for normal differentiation and malignant change in human tissues. Am J Clin Pathol 1987;87:129–39.10.1093/ajcp/87.1.1293541575
DOI: https://doi.org/10.21307/immunohematology-2019-1022 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 89 - 93
Published on: Dec 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 K. Benson, published by American National Red Cross
This work is licensed under the Creative Commons License.